GDTC
Price
$2.40
Change
+$0.16 (+7.17%)
Updated
Apr 3 closing price
Capitalization
27.64M
31 days until earnings call
JSPR
Price
$4.01
Change
-$0.22 (-5.20%)
Updated
Apr 3 closing price
Capitalization
60.54M
Ad is loading...

GDTC vs JSPR

Header iconGDTC vs JSPR Comparison
Open Charts GDTC vs JSPRBanner chart's image
CytoMed Therapeutics
Price$2.40
Change+$0.16 (+7.17%)
Volume$8.8K
Capitalization27.64M
Jasper Therapeutics
Price$4.01
Change-$0.22 (-5.20%)
Volume$232.37K
Capitalization60.54M
GDTC vs JSPR Comparison Chart
Loading...
GDTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GDTC vs. JSPR commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GDTC is a StrongBuy and JSPR is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (GDTC: $2.39 vs. JSPR: $4.01)
Brand notoriety: GDTC and JSPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GDTC: 58% vs. JSPR: 69%
Market capitalization -- GDTC: $27.64M vs. JSPR: $60.54M
GDTC [@Biotechnology] is valued at $27.64M. JSPR’s [@Biotechnology] market capitalization is $60.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GDTC’s FA Score shows that 0 FA rating(s) are green whileJSPR’s FA Score has 2 green FA rating(s).

  • GDTC’s FA Score: 0 green, 5 red.
  • JSPR’s FA Score: 2 green, 3 red.
According to our system of comparison, JSPR is a better buy in the long-term than GDTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GDTC’s TA Score shows that 4 TA indicator(s) are bullish while JSPR’s TA Score has 4 bullish TA indicator(s).

  • GDTC’s TA Score: 4 bullish, 6 bearish.
  • JSPR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, JSPR is a better buy in the short-term than GDTC.

Price Growth

GDTC (@Biotechnology) experienced а +6.44% price change this week, while JSPR (@Biotechnology) price change was -17.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

GDTC is expected to report earnings on May 28, 2025.

JSPR is expected to report earnings on May 10, 2024.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JSPR($60.5M) has a higher market cap than GDTC($27.6M). GDTC YTD gains are higher at: -29.559 vs. JSPR (-81.244).
GDTCJSPRGDTC / JSPR
Capitalization27.6M60.5M46%
EBITDAN/A-74.87M-
Gain YTD-29.559-81.24436%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A71.6M-
Total DebtN/A1.81M-
TECHNICAL ANALYSIS
Technical Analysis
GDTCJSPR
RSI
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
59%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
69%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 19 days ago
70%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
64%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
78%
View a ticker or compare two or three
Ad is loading...
GDTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DARE2.930.02
+0.69%
Dare Bioscience Inc.
WRN1.08-0.02
-1.82%
Western Copper and Gold Corp
EPRT31.81-0.79
-2.42%
Essential Properties Realty Trust
NDAQ73.79-4.51
-5.76%
Nasdaq
BXC72.04-5.99
-7.68%
BlueLinx Holdings

GDTC and

Correlation & Price change

A.I.dvisor tells us that GDTC and CYCN have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GDTC and CYCN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GDTC
1D Price
Change %
GDTC100%
+7.27%
CYCN - GDTC
31%
Poorly correlated
-1.15%
CVKD - GDTC
29%
Poorly correlated
-4.81%
ADIL - GDTC
27%
Poorly correlated
-2.20%
JSPR - GDTC
26%
Poorly correlated
-5.20%
QSI - GDTC
26%
Poorly correlated
-5.69%
More

JSPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, JSPR has been loosely correlated with AUPH. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if JSPR jumps, then AUPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JSPR
1D Price
Change %
JSPR100%
-5.20%
AUPH - JSPR
44%
Loosely correlated
-1.71%
AVXL - JSPR
39%
Loosely correlated
-3.04%
ATNF - JSPR
38%
Loosely correlated
-12.00%
ABCL - JSPR
34%
Loosely correlated
-5.86%
MNMD - JSPR
34%
Loosely correlated
-7.04%
More